Top
US_Flag An official website of the United States government Here's how you know
GOV

The .gov means it's official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

LOCK

The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

 
U.S. Food & Drug Administration
Continuing Education and Accreditation
Division of Learning and Organizational Development
Center for Drug Evaluation and Research

An Overview of Naloxone and FDA’s Efforts to Expand Access

Step Status
Educational Content
Posttest
Evaluation
Starts On: Wed, 4/6/22: 12:00 AM EDT
Ends On: Sun, 12/31/23: 12:00 AM EST
Type: Enduring Material
Credits: 1
Description: This webinar was designed to aid healthcare professionals in understanding the forms of naloxone that are available for the emergency treatment of acute opioid overdose and also increased knowledge of steps that FDA has taken to expand community access to naloxone.
Objectives:
  • Describe what naloxone is, how it works, and the availability of products for treatment of acute opioid
    overdose
  • Identify the steps FDA has taken to encourage prescribers to discuss naloxone with patients
  • Explain FDA’s work to support the development of an over-the-counter (OTC) naloxone product
Additional Information: Review the Activity Announcement for additional details: Announcement Form

Additional Resources: NaloxoneSlides